Molecular and cellular biology of breast cancer
Molecular and cellular biology of breast cancer
Our laboratory is interested in the cellular mechanisms deregulated in breast cancer.
Breast cancer is a heterogeneous disease with a high incidence. The fight against breast cancer presents challenges: tailoring cancer therapy to individual patients and identifying new therapies. The goals of our team are to understand how the deregulation of certain proteins and cellular functions in tumors impacts cancer growth and progression, and then use this knowledge to improve patient management.
The four main research areas developed in the team are:
- Characterization of the StAR related lipid transfer domain 3 (STARD3) protein which represents a vulnerability for HER2-positive breast cancers.
- Studying cellular structures called membrane contact sites that physically connect organelles.
- Determining the function of matrix metalloproteinase 11 (MMP11), a microenvironment protein involved in the tumor cell-breast adipocyte dialogue.
- The study of the link between environment and breast cancer.
Current projects
1: Molecular mechanisms of STARD3 addiction in HER2+ cancers
HER2 (Human Epidermal Receptor 2) is an oncogene activated by gene amplification in many cancers such as breast cancer (15-30%) and gastric cancer (10-30%). HER2 gene amplification leads to the co-amplification of several other genes including StAR related lipid transfer domain-3 (STARD3). The STARD3 gene has been identified in the laboratory and its expression correlates with that of HER2 in breast cancers suggesting that STARD3 plays a role in these cancers. Consistent with this idea, data from our lab and others show that inhibition of STARD3 expression results in a decrease of cell growth in all HER2+ cells, but has no effect on the growth of other cell lines.
The STARD3 gene encodes a protein that has no apparent link to HER2. STARD3 is a cholesterol transporter that acts at contact sites between the endoplasmic reticulum and endosomes.
Our project is to understand how this function of STARD3 promotes the growth of HER2+ cancer cells.
2: Inter-organelle contacts and lipid transport in cancer
Eukaryotic cells are compartmentalized into organelles, each with specialized functions. It has recently been recognized that the exchange of information and metabolites between organelles, in addition to vesicular transport, occurs at regions where the membranes of two distinct organelles come into contact in structures called membrane contact sites.
Our lab has shown that contact sites between endosomes and the endoplasmic reticulum (ER) created by the STARD3 protein (Alpy et al, 2013) enable cholesterol transport between these two organelles (Wilhelm et al, 2017).
The ER, which spans the entire cytoplasm of the cell, is a central in interorganelle communication mediated by contact sites. We have identified a receptor, named MOSPD2, localized on the surface of the ER, which enables the formation of contacts between the ER and many organelles such as endosomes, mitochondria etc... (Di Mattia et al, 2018). Recently, we have shown that the contact sites between the ER and other cellular organelles are regulated by phosphorylation.
Our project is to understand how contact sites are formed and regulated, and what their functions are in cancer cells.
3: Function of MMP11 in tumor metabolism
Matrix metalloproteinase 11 (MMP11) is a protein of the tumor microenvironment that is secreted by normal tumor cells (adipocytes and fibroblasts). Our work has shown that MMP11 participates in the communication between adipocytes and tumor cells, and modulates tumor metabolism.
Our project is to decipher the mechanism of action of MMP11 in the adipocyte-tumor cell dialogue.
4: Environment and breast cancer
Many epidemiological studies link the increase in breast cancer incidence to the environment. Some studies incriminate endocrine disruptors found in pesticides or even metals and present in our daily lives through foodstuffs, hygiene products, drinking water and the air we breathe. In order to know if there is a link between the environment and breast health, our research project, which is based on the Strasbourg breast tumor sample bank, is to measure various molecules (pesticides, metals) in the tumor and the peritumoral fatty tissue.
Publications
-
2016
-
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch
- Nassim Dali-Youcef
- Karim Hnia
- Sébastien Blaise
- Nadia Messaddeq
- Stéphane Blanc
- Catherine Postic
- Philippe Valet
- Catherine Tomasetto
- Marie-Christine Rio
Scientific Reports
-
Touché! STARD3 and STARD3NL tether the ER to endosomes
- Fabien Alpy
- Léa p. Wilhelm
- Catherine Tomasetto
Biochemical Society Transactions ; Volume: 44 ; Page: 493-498
-
[Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?] = Cancer du sein et trisomie 21 : une anomalie génétique qui protège contre le cancer du sein ?
- Camille Martel-Billard
- C. Cordier
- Catherine-Laure Tomasetto
- J. Jegu
- Carole Mathelin
Gynécologie Obstétrique & Fertilité ; Volume: 44 ; Page: 211-7
-
A prospective study to assess the clinical utility of serum HER2 extracellular domain in breast cancer with HER2 overexpression
- Nathalie Reix
- Charlotte Malina
- Marie Pierrette Chenard
- Jean-Pierre Bellocq
- Stéphanie Delpous
- Sébastien Molière
- Anthony Sevrin
- Karl Neuberger
- Catherine Tomasetto
- Carole Mathelin
Breast Cancer Research and Treatment ; Volume: 160 ; Page: 249-259
-
-
2014
-
The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells
- Adrien Rousseau
- Léa Wilhelm
- Catherine Tomasetto
- Fabien Alpy
Tissue Barriers ; Volume: 2 ; Page: e975597
-
Functional relationship between matrix metalloproteinase‐11 and matrix metalloproteinase‐14
- Emilie Buache
- Robert Thai
- Corinne Wendling
- Fabien Alpy
- Adeline Page
- Marie‐pierre Chenard
- Vincent Dive
- Marc Ruff
- Annick Dejaegere
- Catherine Tomasetto
- Marie‐christine Rio
Cancer Medicine ; Volume: 3 ; Page: 1197-1210
-
STARD3: A Lipid Transfer Protein in Breast Cancer and Cholesterol Trafficking
- Fabien Alpy
- Catherine Tomasetto
Cholesterol Transporters of the START Domain Protein Family in Health and Disease. START Proteins - Structure and Function ; Page: 119-138
-
START ships lipids across interorganelle space
- Fabien Alpy
- Catherine Tomasetto
Biochimie ; Volume: 96 ; Page: 85-95
-
An early reduction in GH peak amplitude in preproghrelin-deficient male mice has a minor impact on linear growth
- Rim Hassouna
- Philippe Zizzari
- Catherine-Laure Tomasetto
- Johannes D. Veldhuis
- Oriane Fiquet
- Alexandra Labarthe
- Julie Cognet
- Frederik Steyn
- Chen Chen
- Jacques Epelbaum
- Virginie Tolle
Endocrinology ; Volume: 155 ; Page: 3561-3571
-
Valeur juridique des recommandations de bonne pratique: cas de l'hormonothérapie des cancers du sein [Legal value of the recomendations of good practice: example for breast cancer hormonotherapy]
- Stéphanie Delpous
- Ghislain Benhessa
- Alexandre Bilalis
- Catherine-Laure Tomasetto
- Carole Mathelin
Bulletin du Cancer ; Volume: 101 ; Page: 283-294
-
Members
PhD students
Engineers
Occasionnal collaborators
Collaborations and networks
Guillaume Drin, IPMC, Valbonne FR
Jean Cavarelli, Alastair McEwen et Pierre Poussin-Courmontagne, IGBMC
Toshihide Kobayashi, Faculté de Pharmacie, Illkirch, FR
Jean-Michel Brunel, MCT, Marseille, FR
Yves Nominé, IGBMC
Rachid Thiam, ENS Paris, FR
Tim Levine, UCL, London, UK